Brief: Alumis And Acelyrin Announce Amended Merger Agreement
21/04/2025 12:53
April 21 (Reuters) - Alumis Inc ALMS.O: ALUMIS AND ACELYRIN ANNOUNCE AMENDED MERGER AGREEMENT ALUMIS INC - ACELYRIN STOCKHOLDERS TO RECEIVE 0.4814 SHARES OF ALUMIS PER SHARE ALUMIS INC - ACELYRIN STOCKHOLDERS TO RECEIVE INCREASED OWNERSHIP IN COMBINED COMPANY ALUMIS INC: ALUMIS & ACELYRIN STOCKHOLDERS TO NOW OWN ABOUT 52% AND 48%, RESPECTIVELY ALUMIS INC - EXPECTS RUNWAY TO FUND OPERATIONS INTO 2027 Source text: ID:nGNXbWnw4t Further company coverage: ALMS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alumis
See all newsBrief: Alumis Says Envudeucitinib Improves Psoriasis Symptoms in Phase 3 Data
U.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Alumis set for worst day after lupus drug misses main goal in mid-stage trial
Alumis eyes late-stage lupus study despite trial miss (updated)
Alumis tumbles after lupus drug misses main goal in mid-stage trial